Interestingly, in this cluster, 13 patients (87%) exhibited AP activation and 7 patients (47%) exhibited MBL pathway activation; 6 (40%) patients presented simultaneously AP and MBL pathway activation (Supplementary Table S1). The gene discussed is DHCR7-DT; the disease is alkaline phosphatase measurement.